Advertisement · 728 × 90
#
Hashtag
#Rxcosts
Advertisement · 728 × 90
Top PBMs by 2025 market share Cigna’s Express Scripts continued its lead in the U.S. pharmacy benefit manager market for the second year in a row, processing nearly one-third of all prescription claims, according to a March 30 report from the Drug Channels Institute.

The same three #PBM companies as last year still control 80% of the market. #MarketConsolidation #RxCosts

0 0 0 0
Preview
TN House finance committee unanimously moves forward ‘Fair Rx Act’ amid outcry from CVS Health CVS Health says the bill will force the closure of more than 100 Tennessee stores, but lawmakers argue it will level the playing field for independent pharmacies.

Lawmakers decided to put off their vote to take more time to consider their findings. It’s now on the committee’s March 24 calendar. #Tennessee #FairRX #Legislation #PBM #RxCosts

0 0 0 0
CMS moves forward with 3rd round of Medicare drug negotiations The third round of the Medicare Drug Price Negotiation Program is moving forward with full manufacturer participation.

The manufacturers of all 15 drugs selected for this round have agreed to participate in the #Medicare negotiation program, along with the manufacturer of one drug selected for renegotiation. #RxCosts #CMS

1 1 0 0
Preview
GoodRx launches direct-to-employer program targeting drug costs - Becker's Payer Issues | Payer News GoodRx is moving into the employer benefits market with a new program that lets companies subsidize discounted cash prices on brand-name drugs for their employees. The program, GoodRx Employer…

The program, #GoodRx Employer Direct, launched earlier this year with an initial focus on GLP-1s. The program also includes an employer-branded version of GoodRx’s #telehealth services. #RxCosts #EmployeeBenefits

1 1 0 0
Preview
AmeriHealth Caritas to shut down PBM, move to Optum Rx AmeriHealth Caritas shut down PerformRx PBM and will transition to Optum Rx starting in 2027, maintaining current contracts and limiting job impact.

PerformRx will wrap operations “in their current form” Dec. 31. The switch to Optum Rx will go into effect at the start of 2027. #PBM #Consolidation #Monopolization #RxCosts

0 0 0 0
Preview
PBM trade group demands supply chain transparency for all David Marin told a House panel that manufacturers and wholesalers should get more attention.

PBMs accept the need for more #PriceTransparency. And "it should be applied across the supply chain." #MyOpinion: sounds good to me. #PBM #RxCosts

1 0 0 0
Preview
New federal PBM transparency mandates include $10K-per-day fines for employers Employers should make sure they know who's responsible for paying the PBM noncompliance penalties, a compliance attorney says.

Employers and #PBM that violate the #ReportingRules in the new federal pharmacy benefit manager laws could end up owing $10,000-$100,000 in fines per violation per day. #ouch #ButNeeded #RxCosts

1 0 0 0

Although #TrumpRx may offer savings for some cash-paying patients, pricing comparisons suggest most insured Americans are still likely to find lower costs elsewhere. #RxCosts

1 0 0 0
Preview
Exclusive-Cigna settles FTC insulin case, commits to overhauling drug pricing Feb 4 () - Cigna Corp's Express Scripts has settled the U. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed…

#ExpressScripts' settlement contains provisions requiring it to work with local pharmacies and disclose #RxCosts to employers annually.

1 0 0 0
Preview
Labor Department proposes PBM compensation disclosure rule for self-insured plans - Becker's Payer Issues The Labor Department’s Employee Benefits Security Administration proposed regulation Jan. 29 that would require pharmacy benefit managers to disclose their compensation with self-insured group health…

Going into 2026, #PBM reforms have been picking up steam. The House passed elements of a reform under the Consolidated Appropriations Act (#CAA). Several #pharmacy groups have backed the efforts. #RxCosts #Legislation

1 0 0 0
Preview
Payer CEOs point to hospitals, drug manufacturers for rising costs ahead of congressional hearings - Becker's Payer Issues | Payer News The CEOs of most of the nation’s largest health insurers plan to lay blame for rising healthcare costs on hospitals, pharmaceutical companies and specialty providers during testimony before Congress…

All five CEOs cited #HospitalConsolidation, #RxCosts, lack of #PriceTransparency, and the cost of specialty services and diagnostic testing as the reason for rising premiums. “The cost of #HealthInsurance is driven by the cost of #healthcare. It is a symptom, not a cause."

0 0 0 0
Preview
PBM trade group files federal suit to stop California oversight of self insured plans PCMA says the law violates the ERISA provision that preempts state benefits regulation.

#California, pharmacy groups, and some employer groups have argued that the state needs to act to protect them from #PBM actions. PBMs have argued that other players in the prescription drug #SupplyChain are attacking them mainly because of their success. #RxCosts #ERISA #Litigation

0 0 0 0
Preview
Virginia sues PBMs, manufacturers over alleged insulin pricing scheme The lawsuit alleged a years-long insulin pricing scheme that artificially inflated the price of lifesaving diabetes medications and deceived consumers about those inflated prices.

The complaint alleges that manufacturers required PBMs to inflate drug prices to gain formulary access and then paid an undisclosed amount of the cost back to the #PBM. #RxCosts #Insulin #Drugmakers #Litigation #Virginia

0 0 0 0
Preview
Pharmacy benefit manager fiduciary bill arrives with bipartisan support The bill could also add compensation reporting obligations for PBMs and for health plan TPAs.

The bill, the #PBM Fiduciary, Accountability, Integrity and Reform Act, or PBM FAIR Act, would add a PBM #fiduciary section to #ERISA. In addition to bipartisan support, the ERISA Industry Committee is supporting it. #legislation #RxCosts

0 0 0 0
Preview
Optum Rx says 100% of network community pharmacies in cost-based contracts PBMs are pivoting reimbursement models to protect pharmacies from what they say is an unsustainable status quo.

#OptumRx says its response from participating pharmacies to date has been positive. #PBM #Reimbursement #RxCosts

1 0 1 0
Some hospitals mark up generic cancer drugs 5x commercial rates: Bloomberg Some U.S. hospitals and health systems are marking up generic cancer drugs by more than five times their commercial rates, Bloomberg reported Dec. 17.

Compared to independent physician practices, drug price #markups were 6.59 times and 4.34 times as high at 340B-eligible hospitals and noneligible hospitals, respectively. #RxCosts

1 0 0 0
Preview
New Jersey enacts insulin, inhaler, EpiPen out-of-pocket caps - Becker's Payer Issues | Payer News New Jersey has finalized rules requiring state-regulated insurers to cap out-of-pocket costs on insulin, asthma inhalers and epinephrine auto-injectors. The state published the final regulations Dec.…

The caps apply to the individual and small employer markets, and insurers must provide the medications without a deductible. The regulations also require coverage of hearing aids and cochlear implants under a separate law. #NewJersey #Insulin #RxCosts #EpiPen #Inhalers

0 0 0 0
Preview
Falling prices might lead 33% of U.S. adults to try GLP-1 weight-loss drugs Roughly 5.1% of U.S. adults may now be using GLP-1 agonists to try to control their weight, according to eHealth.

33% of U.S. adults told eHealth that they wanted to try drugs like Wegovy once the price comes down. #GLP1 #RxCosts

0 0 0 0
Preview
Mark Cuban's Cost Plus Drugs, Humana exploring partnership to tackle employer drug costs Mark Cuban's Cost Plus Drugs and Humana are exploring a potential partnership to help lower the cost of prescription drugs for employers. | Mark Cuban's Cost Plus Drugs and Humana are exploring a…

Direct-to-employer programs could save members "billions and billions of dollars," #MarkCuban asserted. #Humana #RxCosts #PBM

0 0 0 0
Preview
House Democrats introduce bill to expand drug price negotiation to commercial market Democrats in the House have introduced a new bill that aims to further expand Medicare's ability to negotiate drug prices.

The bill, a follow-up to the #InflationReductionAct, also expands this ability to the commercial market, which would reach more than 188 million additional Americans. #Legislation #RxCosts

0 0 0 0
Preview
Colorado becomes 1st state to cap drug prices Colorado finalized the nation’s first prescription drug price cap Oct. 3, establishing an upper payment limit for Enbrel, an autoimmune medication…

The #rulemaking process began May 23 and concluded Oct. 3, setting a $600 cap on a 50-milligram dose of #Enbrel. #Colorado #RxCosts #DrugCosts #prescriptions

0 0 0 0
Preview
Nearly 700 drugs see price hikes under Trump: Report Prices for 688 prescription medications have increased since President Donald Trump took office, according to a Sept. 29 report from Sen. Bernie Sanders…

The report marks 60 days since President Trump sent letters to #drugmakers requesting price reductions. In that time [alone], 87 drugs have gone up in price, with a median increase of 8%. Companies raised prices after receiving the administration’s request. #RxCosts

0 0 0 0
Preview
Pfizer to lower some drug prices as White House builds "TrumpRX" website Pfizer's CEO said President Trump's threat of tariffs motivated his company to take swift action.

The #Pfizer agreement is a part of the White House agenda to secure "most favored nation" pricing with #pharmaceutical manufacturers. Neither Pfizer nor the White House have released specific #drug prices yet. #RxCosts #StoppedClocks

1 0 0 0
Preview
New report warns of double-digit hikes in pharmacy costs A primary contributor is the lack of competition in the pharmaceutical market, especially for brand-name drugs protected by patents.

The survey identified the top five #strategies that respondents (including #employers) are using to mitigate #pharmaceutical expenses without compromising the quality of care. #RxCosts #EmployeeBenefits #PharmacyBenefits

0 0 0 0
Preview
PBM market dominated by four giants, raising concerns about costs, competition Nine of the 10 largest PBMs share ownership with health insurers.

This report comes at a time of heightened scrutiny of low competition and high vertical integration in the #PBM industry. #RxCosts #RxBenefits

0 0 0 0
Preview
Trump demands pharma companies slash drug prices in next 60 days President Trump sent letters Thursday to 17 of the world’s largest drug companies, telling them to take more steps to slash the prices of prescription drugs to match the lowest price in certain for…

The letters represent an escalation of the administration’s push to tie the prices of #prescriptions in the U.S. to the lowest found among comparably wealthy nations. #RxCosts #StoppedClocks #TrumpAdministration buff.ly/g7aMQiw

0 0 0 0
Preview
Pharmaceutical costs expected to rise 3.35% in 2026: Vizient - Becker's Hospital Review | Healthcare News & Analysis Pharmaceutical prices are expected to rise by 3.35% in 2026, according to Vizient’s latest Pharmacy Market Outlet report, released in July.  The report found that price pressures are easing in…

#Pediatric #drugs are expected to have the highest inflation rate, at 3.93%. #ImmuneGlobulin products have become the top drugs by spend. Pharmaceutical #tariffs were not factored into the 2026 projection. #RxCosts #Prescriptions

0 0 0 0
Preview
Medical Cost Trend at 8.5% in 2026? PwC Sees "No End in Sight" for Increased Healthcare Spending - HealthPopuli.com For the third year in a row, medical cost trend — the expected increase of health care costs by health plans — will be 8.5% for group health insurance. This contrasts with a low of 5.5% in 2022 when c...

Medical cost trend will reach 8.5% in 2026 for #healthplans via @PwC Behind the Numbers

What's #healthcare cost-increasing? #Hospitals costs, #GLP1s & meds, #RCM & #behavioralhealth

tinyurl.com/yymbsaa6

#HealthInsurance #HealthCosts #HealthEconomics #Mentalhealth #Rxcosts

0 0 0 0
Preview
Trump floats 200 percent tariffs on pharmaceutical imports ‘very soon’ President Trump on Tuesday threatened to impose up to 200 percent tariffs on pharmaceutical products imported into the U.S. “very soon.”  “If they have to bring the pharmaceuticals into the co…

More details will likely be announced at the end of the month, once a probe into the issue is completed. #Tariffs #Rx #RxCosts #TrumpAdministration #pharmaceuticals buff.ly/WlqIrQY

0 0 0 0
Preview
GLP-1 obesity and diabetes drugs drive 17% of employee pharmacy claims, CBIZ reports The firm's benefits clients spent three times more on the drugs last year than in 2022.

Wegovy and other #GLP1 obesity and blood sugar control drugs accounted for 17% of pharmacy benefits spending in 2024, up from 13% in 2023. #RxCosts buff.ly/1bUD59S

0 0 0 0